Article in deDeutsch Article in enEnglish Article in esEspañol Article in frFrançais Article in nlNederlands Article in ptPortuguês

Japan to Start Clinical Trials for Artificial Blood This Year

10
3
• Health • • 1 min read • 0% read

Japan is launching clinical trials for artificial blood, aiming to revolutionize medical blood supply by 2030.

Japan to Start Clinical Trials for Artificial Blood This Year
Facebook X LinkedIn Bluesky WhatsApp
de flag en flag es flag fr flag nl flag pt flag

Japan is pioneering clinical trials for artificial blood, a breakthrough that could address global blood supply shortages. The trials, led by Nara Medical University, build on successful early-stage tests of hemoglobin vesicles—artificial blood cells proven safe and effective for oxygen delivery.

The study will administer 100 to 400 milliliters of artificial blood to assess safety before broader efficacy trials. If successful, this innovation could enter clinical use by 2030, solving critical challenges in blood donation and storage worldwide.

Related

FDA Clears First Blood Test for Early Alzheimer's Detection
Health
• Health
AI relevance 94.4%

FDA Clears First Blood Test for Early Alzheimer's Detection

FDA approves first blood test detecting Alzheimer's biomarkers pTau217 and beta-amyloid 1-42 ratio. The 91.7%...

Nanomedicine Breakthrough: Microscopic Drug Delivery Enters Trials
Health
• Health
AI relevance 88.9%

Nanomedicine Breakthrough: Microscopic Drug Delivery Enters Trials

Nanomedicine reaches clinical trials with microscopic drug delivery systems that target diseases precisely....

AI Clinical Trial Accelerator Revolutionizes Drug Development
Ai
• Ai
AI relevance 83.3%

AI Clinical Trial Accelerator Revolutionizes Drug Development

AI clinical trial accelerators are revolutionizing drug development by compressing timelines, improving success...

Breakthrough in Alzheimer’s Treatment: New Drug Shows Promise in Reversing Early-Stage Symptoms
Health
• Health
AI relevance 77.8%

Breakthrough in Alzheimer’s Treatment: New Drug Shows Promise in Reversing Early-Stage Symptoms

A new drug by Eli Lilly and Biogen shows promise in reversing early-stage Alzheimer’s symptoms, offering hope to...

Breakthrough Immunotherapy Shows Promise in Cancer Trial
Health
• Health
AI relevance 72.2%

Breakthrough Immunotherapy Shows Promise in Cancer Trial

PRL3-zumab immunotherapy shows unprecedented success in Phase II trials for advanced solid tumors, with excellent...

AI Clinical Trial Accelerator Reshapes Drug Development
Ai
• Ai
AI relevance 66.7%

AI Clinical Trial Accelerator Reshapes Drug Development

AI is revolutionizing clinical trials, accelerating drug development with 80-90% phase 1 success rates and reducing...